Myeloid-lineage blasts with histiocytoid differentiation in TP53 mutated acute myeloid leukemia: a deceptive morphologic overlap with mature malignant histiocytic neoplasms
Here, we report a case of TP53-mutated acute myeloid leukemia (AML) with monocytic differentiation that showed striking histiocytoid morphologic transformation following induction chemotherapy. Post-treatment blasts demonstrated significant morphologic overlap with mature malignant histiocytic neoplasms, particularly histiocytic sarcoma subtype, creating a potential diagnostic pitfall. Retained myeloperoxidase expression, together with the absence of cyclin D1 expression, supported a diagnosis of persistent AML rather than divergent histiocytic differentiation.
Authors
- Neha Seth (ORCID: https://orcid.org/0000-0002-3299-4201)
- Aishwarya Ravindran (ORCID: https://orcid.org/0000-0003-4503-440X)
Institutions
- Northwell Health (US)
- Mayo Clinic (US)
- Mayo Clinic in Arizona (US)
- North Shore Diabetes and Endocrine Associates (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Blood Research
- Published
- 2026-08-03
- DOI
- https://doi.org/10.1007/s44313-026-00156-z
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00